Chugai and Debiopharm Announce an Exclusive License Agreement for FF284

News   Jan 08, 2013

 
Chugai and Debiopharm Announce an Exclusive License Agreement for FF284
 
 
 

RELATED ARTICLES

Nothing Wasted

News

New study reveals breast cancer cells recycle their own ammonia waste as fuel.

READ MORE

Study of What Makes Cells Resistant to Radiation Could Improve Cancer Treatments

News

Electron paramagnetic resonance spectroscopy has shown that the same molecular structures provide resistance to the harmful effects of ionizing radiation for every type of living cell found on Earth, from microorganisms to human cells.

READ MORE

Genomics Researchers Showcase their Applications of Droplet Digital PCR at ASHG 2017 Annual Meeting

News

The sensitivity and reliability of Droplet Digital PCR will be showcased in over a dozen presentations at the American Society of Human Genetics (ASHG) 2017 Annual Meeting.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE